Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by groundhemlockon May 01, 2019 12:15pm

146 Views

Post# 29695421

Decision Document

According to Sedar filing April 29,2019 A decision document and Preliminary base shelf prospectus was filed. Looks like other P.P.'s are coming soon. Any one to estimate number of shares and price involved? According to the base document last years cash burn was $ 101K /month with Future estimate at $ 183k/month. This would have to be a large P.P.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec